Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
Autor: | Alessio Degl'Innocenti, Lisa Tanser, Holger J. Schünemann, Alan N. Barkun, S van Zanten, Diane Heels-Ansdell, Carlo A Fallone, David Armstrong, Gordon H. Guyatt, Peggy Austin, Samer El-Dika, Ingela Wiklund, Naoki Chiba |
---|---|
Rok vydání: | 2004 |
Předmět: |
medicine.medical_specialty
Hepatology Esophageal disease business.industry digestive oral and skin physiology Gastroenterology Reflux Heartburn Disease medicine.disease Confidence interval Esomeprazole Clinical trial Quality of life Internal medicine medicine Pharmacology (medical) medicine.symptom business medicine.drug |
Zdroj: | Alimentary Pharmacology & Therapeutics. 20:1161-1169 |
ISSN: | 0269-2813 |
DOI: | 10.1111/j.1365-2036.2004.02257.x |
Popis: | Summary Background : The accuracy of physicians’ assessment of the severity of gastro-oesophageal reflux disease is unclear. Aim : To correlate physician and patient assessment of gastro-oesophageal reflux disease severity and its response to treatment. Methods : Adult uninvestigated gastro-oesophageal reflux disease patients (n = 217) completed symptom and health-related quality of life questionnaires at baseline and after treatment with esomeprazole 40 mg p.o. daily. Pearson coefficients quantified correlations between physician assessments and patient responses. Results : At baseline, the strongest correlations were heartburn severity (0.31), overall symptom severity (0.44) and a domain of the quality of life in reflux and dyspepsia questionnaire (0.31) (P |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |